Firas J Al Badarin1, John A Spertus, Kensey L Gosch, Donna M Buchanan, Paul S Chan. 1. Saint Luke's Mid America Heart Institute, Kansas City, MO; University of Missouri-Kansas City, Kansas City, MO; Prairie Heart Institute of Southern Illinois, Carbondale, IL. Electronic address: albadarin@gmail.com.
Abstract
BACKGROUND: Whereas statins are considered the cornerstone of prevention after acute myocardial infarction (AMI), concerns about worsening depression in association with their use have been raised. METHODS: Using data from 2 prospective AMI registries (PREMIER and TRIUMPH), we examined the change in depressive symptoms from baseline and at 1, 6 and 12 months among statin-naïve patients who were and were not discharged on a statin. Depressive symptoms were assessed with the 8-item Patient Health Questionnaire (PHQ-8). Within-group change in PHQ-8 scores from baseline to each follow-up period was assessed using paired t tests. A repeated-measures propensity-matched analysis examined whether changes in PHQ-8 scores from baseline were different between statin-treated and statin-untreated patients. RESULTS: Of 3,675 patients not previously treated with statins, 3,050 (83%) were discharged on a statin and 625 (17%) were not. Scores of PHQ-8 in the statin group decreased from baseline by a mean (± SD) of 0.9 (± 5.1), 1.2 (± 5), and 1.1 (± 5.1) at 1, 6, and 12 months, respectively. Corresponding changes in the nonstatin group were 0.9 (± 5.2), 1.3 (± 5.1), and 1.5 (± 5.8), respectively (P < .0001 for all comparisons). After propensity matching, 451 patients not discharged on statins with 1,240 patients discharged on statins, the mean change in PHQ-8 scores between baseline and the 3 follow-up time points was not significantly different between groups (mean between-group difference at 1 month: -0.13, 95% CI [-0.69 to 0.43], P = .65; at 6 months: -0.07, 95% CI [-0.66 to 0.52], P = .82; and at 12 months: -0.05, 95% CI [-0.67 to 0.58], P = .88). CONCLUSIONS: Initiation of statins after AMI was not associated with worsening depression.
BACKGROUND: Whereas statins are considered the cornerstone of prevention after acute myocardial infarction (AMI), concerns about worsening depression in association with their use have been raised. METHODS: Using data from 2 prospective AMI registries (PREMIER and TRIUMPH), we examined the change in depressive symptoms from baseline and at 1, 6 and 12 months among statin-naïve patients who were and were not discharged on a statin. Depressive symptoms were assessed with the 8-item Patient Health Questionnaire (PHQ-8). Within-group change in PHQ-8 scores from baseline to each follow-up period was assessed using paired t tests. A repeated-measures propensity-matched analysis examined whether changes in PHQ-8 scores from baseline were different between statin-treated and statin-untreated patients. RESULTS: Of 3,675 patients not previously treated with statins, 3,050 (83%) were discharged on a statin and 625 (17%) were not. Scores of PHQ-8 in the statin group decreased from baseline by a mean (± SD) of 0.9 (± 5.1), 1.2 (± 5), and 1.1 (± 5.1) at 1, 6, and 12 months, respectively. Corresponding changes in the nonstatin group were 0.9 (± 5.2), 1.3 (± 5.1), and 1.5 (± 5.8), respectively (P < .0001 for all comparisons). After propensity matching, 451 patients not discharged on statins with 1,240 patients discharged on statins, the mean change in PHQ-8 scores between baseline and the 3 follow-up time points was not significantly different between groups (mean between-group difference at 1 month: -0.13, 95% CI [-0.69 to 0.43], P = .65; at 6 months: -0.07, 95% CI [-0.66 to 0.52], P = .82; and at 12 months: -0.05, 95% CI [-0.67 to 0.58], P = .88). CONCLUSIONS: Initiation of statins after AMI was not associated with worsening depression.
Authors: Julie A Pasco; Geoffrey C Nicholson; Lana J Williams; Felice N Jacka; Margaret J Henry; Mark A Kotowicz; Hans G Schneider; Brian E Leonard; Michael Berk Journal: Br J Psychiatry Date: 2010-11 Impact factor: 9.319
Authors: Paul S Chan; William J Oetgen; Donna Buchanan; Kristi Mitchell; Fran F Fiocchi; Fengming Tang; Philip G Jones; Tracie Breeding; Duane Thrutchley; John S Rumsfeld; John A Spertus Journal: J Am Coll Cardiol Date: 2010-06-29 Impact factor: 24.094
Authors: Nancy M Allen LaPointe; Fang-Shu Ou; Sara B Calvert; Chiara Melloni; Judith A Stafford; Tina Harding; Karen P Alexander; Eric D Peterson Journal: Am Heart J Date: 2010-04 Impact factor: 4.749
Authors: Britta Haenisch; Karoline Linsel; Michael Brüss; Ralf Gilsbach; Peter Propping; Markus M Nöthen; Marcella Rietschel; Rolf Fimmers; Wolfgang Maier; Astrid Zobel; Susanne Höfels; Vera Guttenthaler; Manfred Göthert; Heinz Bönisch Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2009-10-05 Impact factor: 3.568
Authors: Robert M Carney; Kenneth E Freedland; Brian Steinmeyer; James A Blumenthal; Lisa F Berkman; Lana L Watkins; Susan M Czajkowski; Matthew M Burg; Allan S Jaffe Journal: J Affect Disord Date: 2008-01-11 Impact factor: 4.839
Authors: Kurt Kroenke; Tara W Strine; Robert L Spitzer; Janet B W Williams; Joyce T Berry; Ali H Mokdad Journal: J Affect Disord Date: 2008-08-27 Impact factor: 4.839
Authors: Amit Kumar; Gregg C Fonarow; Kim A Eagle; Alan T Hirsch; Robert M Califf; Mark J Alberts; William E Boden; P Gabriel Steg; Mingyuan Shao; Deepak L Bhatt; Christopher P Cannon Journal: Crit Pathw Cardiol Date: 2009-09
Authors: Amelia J McFarland; Shailendra Anoopkumar-Dukie; Devinder S Arora; Gary D Grant; Catherine M McDermott; Anthony V Perkins; Andrew K Davey Journal: Int J Mol Sci Date: 2014-11-10 Impact factor: 5.923